ArticleFrontiers in pharmacology2021

Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma.

Zhong-Kun Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.